Novel malabsorption panel speeds diagnosis
Test in Focus
Timely diagnosis is key for children with chronic diarrhea or unexplained weight loss. In this "Test in Focus" episode of the "Answers From the Lab" podcast, Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ novel malabsorption panel combines four existing tests to yield faster results from a single stool sample.
"Our panel can narrow down the differential diagnosis swiftly and easily," Dr. Hopson says. "Stool testing for children can be quite cumbersome. Performing all four tests in one setting is going to help patients and clinicians."
The panel combines the laboratory's existing pancreatic elastase, calprotectin, reducing substance and alpha-1-antitrypsin tests. It's the only existing panel that allows all four tests to be run at the same time with a single specimen.
Listen to learn more about Mayo Clinic Laboratories' pediatric malabsorption panel.
Note: Podcasts will not playback on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.
Container/Tube: Stool container
Specimen Volume: 18 g split between 2 containers, each containing half of the specimen
Analytic time: 4 to 6 days
Days performed: Monday through Friday
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to provide clear answers on reproductive risks and to guide decision-making.
Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ malabsorption panel can provide timelier diagnosis for children with chronic diarrhea or unexplained weight loss. The novel panel, which bundles four existing tests, requires just one stool sample.